Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

RINGSTED DYREKLINIK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   3.7% 2.9% 1.8% 1.8% 3.9% 2.1% 11.6% 11.6%   Credit score (0-100)   53 60 72 70 50 66 21 21   Credit rating   BBB BBB A A BBB A BB BB   Credit limit (kDKK)   0.0 0.0 2.2 2.9 0.0 0.3 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   4,339 4,595 5,726 6,715 5,864 5,893 0.0 0.0   EBITDA   641 914 1,220 1,610 405 588 0.0 0.0   EBIT   484 744 1,038 1,317 68.5 250 0.0 0.0   Pre-tax profit (PTP)   436.9 703.8 1,008.4 1,283.9 18.1 225.4 0.0 0.0   Net earnings   344.3 547.3 786.2 1,003.0 16.1 177.5 0.0 0.0   Pre-tax profit without non-rec. items   437 704 1,008 1,284 18.1 225 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Tangible assets total   4,721 4,588 4,877 4,937 4,715 4,593 0.0 0.0   Shareholders equity total   1,197 1,529 2,094 2,871 2,658 2,835 2,635 2,635   Interest-bearing liabilities   2,760 2,484 2,700 2,562 2,434 2,307 0.0 0.0   Balance sheet total (assets)   5,340 5,385 6,422 7,051 6,141 6,379 2,635 2,635   Net Debt   2,751 2,365 2,118 2,230 1,683 1,821 -2,635 -2,635     See the entire balance sheet 1000.0 Volume  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   4,339 4,595 5,726 6,715 5,864 5,893 0.0 0.0   Gross profit growth   9.8% 5.9% 24.6% 17.3% -12.7% 0.5% -100.0% 0.0%   Employees   10 11 12 12 12 11 0 0   Employee growth %   11.1% 10.0% 9.1% 0.0% 0.0% -8.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   5,340 5,385 6,422 7,051 6,141 6,379 2,635 2,635   Balance sheet change%   2.5% 0.8% 19.3% 9.8% -12.9% 3.9% -58.7% 0.0%   Added value   641.2 913.8 1,219.8 1,609.7 361.1 587.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -123 -302 106 -233 -558 -406 -4,647 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   11.1% 16.2% 18.1% 19.6% 1.2% 4.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   9.3% 13.9% 17.6% 19.7% 1.1% 4.1% 0.0% 0.0%   ROI %   12.0% 18.1% 22.8% 25.1% 1.3% 4.8% 0.0% 0.0%   ROE %   30.4% 40.2% 43.4% 40.4% 0.6% 6.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Equity ratio %   22.4% 28.4% 32.6% 40.7% 43.3% 44.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   429.0% 258.8% 173.6% 138.5% 416.0% 309.7% 0.0% 0.0%   Gearing %   230.6% 162.5% 128.9% 89.2% 91.6% 81.4% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   1.9% 1.7% 1.2% 1.6% 2.1% 1.2% 0.0% 0.0%   1000.0 Liquidity  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Quick Ratio   0.2 0.3 0.7 1.1 0.9 0.9 0.0 0.0   Current Ratio   0.4 0.6 1.0 1.3 1.4 1.4 0.0 0.0   Cash and cash equivalent   9.8 119.7 581.8 331.6 750.6 486.1 0.0 0.0   1000.0 Capital use efficiency  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -905.3 -575.5 -58.3 540.0 412.9 533.5 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   64 83 102 134 30 53 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   64 83 102 134 34 53 0 0   EBIT / employee   48 68 86 110 6 23 0 0   Net earnings / employee   34 50 66 84 1 16 0 0